Improved contemporary surgical management of insulinomas: A 25-year experience at the Massachusetts general hospital

Annals of Surgery

Volumn 247, Issue 1, 2008, Pages 165-172

  Nikfarjam, Mehrdad ^a   Warshaw, Andrew L ^a   Axelrod, Lloyd ^a   Deshpande, Vikram ^a   Thayer, Sarah P ^a   Ferrone, Cristina R ^a   Fernández Del Castillo, Carlos ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SURGERY; CANCER SURVIVAL; CONFUSION; DATA ANALYSIS; DEMOGRAPHY; DIAPHORESIS; DISEASE DURATION; ECHOGRAPHY; ENDOCRINE TUMOR; ENDOSCOPIC ECHOGRAPHY; ENUCLEATION; EXPERIENCE; FEMALE; GENERAL HOSPITAL; HUMAN; INSULINOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PALPATION; PANCREAS FISTULA; PANCREAS RESECTION; PANCREATICODUODENECTOMY; PATHOLOGY; PEROPERATIVE ECHOGRAPHY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SCHOOL CHILD; SENSITIVITY ANALYSIS; SURGICAL TECHNIQUE; SURVIVAL; SYMPTOM; TERTIARY HEALTH CARE; UNITED STATES; VISUAL DISORDER; WEIGHT GAIN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; CHILD; FEMALE; HUMANS; INSULINOMA; MALE; MASSACHUSETTS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PANCREATIC NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 37549013340     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31815792ed     Document Type: Article

References (39)

1. Service FJ, McMahon MM, O'Brien PC, et al. Functioning insulinoma-incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc. 1991;66:711-719.
2. Grant CS. Insulinoma. Best Pract Res Clin Gastroenterol. 2005;19:783-798.
3. Stefanini P, Carboni M, Patrassi N, et al. Beta-islet cell tumors of the pancreas: results of a study on 1,067 cases. Surgery. 1974;75:597-609.
4. Thakker RV. Multiple endocrine neoplasia type 1. Endocrinol Metab Clin North Am. 2000;29:541-567.
5. Mallery JS, Centeno BA, Hahn PF, et al. Pancreatic tissue sampling guided by EUS, CT/US, and surgery: a comparison of sensitivity and specificity. Gastrointest Endosc. 2002;56:218 -224.
6. Warshaw AL. Conservation of the spleen with distal pancreatectomy. Arch Surg. 1988;123:550 -553.
7. Bassi C, Dervenis C, Butturini G, et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005;138:8-13.
8. Kloppel G, Perren A, Heitz PU. The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Ann N Y Acad Sci. 2004;1014:13-27.
9. Wilder RM, Allan FM, Power MH, et al. Carcinoma of the islands of the pancreas: hyperinsulinism and hypoglycemia. JAMA. 1927;89:348-355.
10. Howland G, Campbell WR, Maltby EJ, et al. Dysinsulinism: convulsions and coma due to islet cell tumor of the pancreas with operation and cure. JAMA. 1929;93:647.
11. Rothmund M, Angelini L, Brunt LM, et al. Surgery for benign insulinoma: an international review. World J Surg. 1990;14:393-398; discussion 398-399.
12. Boukhman MP, Karam JM, Shaver J, et al. Localization of insulinomas. Arch Surg. 1999;134:818-822; discussion 822-813.
13. Lo CY, Lam KY, Kung AW, et al. Pancreatic insulinomas. A 15-year experience. Arch Surg. 1997;132:926-930.
14. Grant CS. Gastrointestinal endocrine tumours. Insulinoma. Baillieres Clin Gastroenterol. 1996;10:645- 671.
15. Boukhman MP, Karam JH, Shaver J, et al. Insulinoma - experience from 1950 to 1995. West J Med. 1998;169:98-104.
16. Proye C, Boissel P. Preoperative imaging versus intraoperative localization of tumors in adult surgical patients with hyperinsulinemia: a multicenter study of 338 patients. World J Surg. 1988;12:685-690.
17. Falconi M, Molinari E, Carbognin G, et al. What preoperative assessment is necessary for insulinomas? Calculating the degree of waste: analysis of 29 cases. Chir Ital. 2002;54:597-604.
18. Hashimoto LA, Walsh RM. Preoperative localization of insulinomas is not necessary. J Am Coll Surg. 1999;189:368-373.
19. Norton JA, Shawker TH, Doppman JL, et al. Localization and surgical treatment of occult insulinomas. Ann Surg. 1990;212:615-620.
20. Norton JA. Intraoperative methods to stage and localize pancreatic and duodenal tumors. Ann Oncol. 1999;10(Suppl 4):182-184.
21. McLean AM, Fairclough PD. Endoscopic ultrasound in the localisation of pancreatic islet cell tumours. Best Pract Res Clin Endocrinol Metab. 2005;19:177-193.
22. Anderson MA, Carpenter S, Thompson NW, et al. Endoscopic ultrasound is highly accurate and directs management in patients with neuroendocrine tumors of the pancreas. Am J Gastroenterol. 2000;95:2271-2277.
23. Zimmer T, Stolzel U, Bader M, et al. Endoscopic ultrasonography and somatostatin receptor scintigraphy in the preoperative localisation of insulinomas and gastrinomas. Gut. 1996;39:562-568.
24. Wiesli P, Brandle M, Schmid C, et al. Selective arterial calcium stimulation and hepatic venous sampling in the evaluation of hyperin-sulinemic hypoglycemia: potential and limitations. J Vasc Interv Radiol. 2004;15:1251-1256.
25. Reynolds LR, Park AE, Miller RE, et al. Combined use of calcium infusion localization and a minimally invasive surgical procedure in the management of insulinoma. Endocr Pract. 2002;8:329-334.
26. Pasieka JL, McLeod MK, Thompson NW, et al. Surgical approach to insulinomas. Assessing the need for preoperative localization. Arch Surg. 1992;127:442- 447.
27. Finlayson E, Clark OH. Surgical treatment of insulinomas. Surg Clin North Am. 2004;84:775-785.
28. Angelini L, Bezzi M, Tucci G, et al. The ultrasonic detection of insulinomas during surgical exploration of the pancreas. World J Surg. 1987;11:642-647.
29. Hirshberg B, Libutti SK, Alexander HR, et al. Blind distal pancreatectomy for occult insulinoma, an inadvisable procedure. J Am Coll Surg. 2002;194:761-764.
30. Galbut DL, Markowitz AM. Insulinoma: diagnosis, surgical management and long-term follow-up. Review of 41 cases. Am J Surg. 1980;139:682- 690.
31. Balcom JHt, Rattner DW, Warshaw AL, et al. Ten-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization. Arch Surg. 2001;136:391-398.
32. Menegaux F, Schmitt G, Mercadier M, et al. Pancreatic insulinomas. Am J Surg. 1993;165:243-248.
33. O'Riordain DS, O'Brien T, van Heerden JA, et al. Surgical management of insulinoma associated with multiple endocrine neoplasia type I. World J Surg. 1994;18:488-493; discussion 493-484.
34. Demeure MJ, Klonoff DC, Karam JH, et al. Insulinomas associated with multiple endocrine neoplasia type I: the need for a different surgical approach. Surgery. 1991;110:998-1004; discussion 1004-1005.
35. Norton JA, Kivlen M, Li M, et al. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors. Arch Surg. 2003;138:859-866.
36. Danforth DN Jr, Gorden P, Brennan MF. Metastatic insulin-secreting carcinoma of the pancreas: clinical course and the role of surgery. Surgery. 1984;96:1027-1037.
37. Deshpande V, Fernandez-del Castillo C, Muzikansky A, et al. Cytokeratin 19 is a powerful predictor of survival in pancreatic endocrine tumors. Am J Surg Pathol. 2004;28:1145-1153.
38. Hochwald SN, Zee S, Conlon KC, et al. Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups. J Clin Oncol. 2002;20:2633-2642.
39. Service FJ, Dale AJ, Elveback LR, et al. Insulinoma: clinical and diagnostic features of 60 consecutive cases. Mayo Clin Proc. 1976;51:417-429.